Use of N-desmethylclozapine and related compounds as dopamine stabilizing agents

Details for Australian Patent Application No. 2006231497 (hide)

Owner Acadia Pharmaceuticals Inc.

Inventors Burstein, Ethan S.

Agent Griffith Hack

Pub. Number AU-A-2006231497

PCT Pub. Number WO2006/107948

Priority 60/668,295 04.04.05 US; 60/730,193 25.10.05 US

Filing date 3 April 2006

Wipo publication date 12 October 2006

International Classifications

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

Event Publications

27 September 2007 PCT application entered the National Phase

  PCT publication WO2006/107948 Priority application(s): WO2006/107948

1 November 2007 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 05 Sep 2007

11 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006231498-Methods of protection from oxidative stress

2006231495-Bone cement compositions and the like comprising an RNAIII-inhibiting peptide